Results 161 to 170 of about 17,529 (206)

Relationship of teicoplanin MICs to treatment failure in teicoplanin-treated patients with methicillin-resistant Staphylococcus aureus pneumonia

Journal of Microbiology, Immunology and Infection, 2013
Background/PurposeThe objective of this study was to determine the predictive value of teicoplanin minimal inhibitory concentrations (MICs) for treatment failure among patients with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.MethodsIn ...
Chien-Chang Yang, Ju-Hsin Chia, Ting-Shu Wu   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Teicoplanin

Chemotherapy, 2009
We investigated the pharmacokinetic properties of teicoplanin, after 200 mg i.v. and i.m. administration in 10 healthy male subjects by assuming a three-compartment open model with elimination from the central compartment. The mean peak plasma level was 7.16 μg/ml reached after 2.26 h. The half-life, the plasma and renal clearances, evaluated from i.v.
RIPA, Sandro, L. Ferrante, MIGNINI, Fiorenzo, E. Falcioni   +3 more
openaire   +3 more sources

Teicoplanin

Reactions Weekly, 2018
C. Vidal, W.-R. Külpmann
  +5 more sources

Teicoplanin revisited

Journal of Antimicrobial Chemotherapy, 1988
A H, Williams, R N, Grüneberg
openaire   +2 more sources

Teicoplanin

Drugs & Therapy Perspectives, 1994
  +4 more sources

Teicoplanin

Reactions Weekly, 2008
  +4 more sources

Teicoplanin

Reactions Weekly, 2021
openaire   +2 more sources

Teicoplanin

2020
Beth P. Goldstein, Rita Rosina, Francesco Parenti   +2 more
openaire   +1 more source

Teicoplanin

Reactions Weekly
  +6 more sources

Teicoplanin see Vancomycin/teicoplanin

Reactions Weekly, 1990
openaire   +1 more source